Abstract | BACKGROUND: HYPOTHESIS/OBJECTIVE: To assess the clinical response in FAD affected dogs over the 12-week period following a single oral fluralaner treatment. ANIMALS: Twenty client-owned dogs were diagnosed with FAD on the basis of compatible clinical signs and a positive response in flea antigen tests, using intradermal and or serological methods. METHODS: An open-label small-scale study with all dogs receiving a single oral fluralaner treatment. All enrolled dogs were diagnosed with FAD and then clinically monitored at 4-week intervals for 12 weeks. Twenty dogs completed the study. RESULTS: All dogs were flea-free at all post-treatment assessments except for one dog that had a single flea at the first post-enrollment assessment at 4 weeks. At the 4-week post-treatment assessment active FAD signs had resolved in all dogs; at 8 weeks post-treatment, two dogs showed mild signs. All clinical signs of FAD had resolved at the final assessment of 12 weeks after treatment. CONCLUSIONS AND CLINICAL IMPORTANCE: A single administration of fluralaner alleviated or resolved signs associated with FAD in all treated dogs over the recommended 12-week treatment period.
|
Authors | Petr Fisara, Michael Shipstone, Andrew von Berky, Janet von Berky |
Journal | Veterinary dermatology
(Vet Dermatol)
Vol. 26
Issue 6
Pg. 417-20, e97-8
(Dec 2015)
ISSN: 1365-3164 [Electronic] England |
PMID | 26271195
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 The Authors. Veterinary Dermatology published by John Wiley & Sons Ltd on behalf of Intervet Australia Pty Ltd. |
Chemical References |
- A1443 compound
- Insecticides
- Isoxazoles
|
Topics |
- Administration, Oral
- Animals
- Dermatitis, Allergic Contact
(drug therapy, veterinary)
- Dog Diseases
(drug therapy, parasitology)
- Dogs
- Female
- Flea Infestations
(immunology, veterinary)
- Insecticides
(administration & dosage, therapeutic use)
- Isoxazoles
(administration & dosage, therapeutic use)
- Male
|